Conc. μgmL-1 |
HCT |
ENP |
FRS |
%Recovery |
%RSD |
%Recovery |
%RSD |
%Recovery |
%RSD |
2.5 |
100 |
0 |
100 |
0 |
100 |
0 |
5 |
100 |
0.1 |
100 |
0.1 |
100 |
0.5 |
10 |
101 |
0.2 |
101 |
0.4 |
101 |
0.2 |
15 |
11.2 |
0.01 |
11.2 |
0 |
11.2 |
0 |
25 |
100.02 |
0.4 |
100.02 |
0.1 |
100.02 |
0.7 |
50 |
100 |
0.2 |
100 |
0.6 |
100 |
0.2 |
100 |
101 |
0.5 |
101 |
0.2 |
101 |
0.3 |
Assay (spiking method) |
80 |
100 |
0.1 |
100 |
0.1 |
100 |
0.1 |
100 |
100.2 |
0.2 |
100.2 |
0.2 |
100.2 |
0.1 |
120 |
100.3 |
0.1 |
100.3 |
0.1 |
100.3 |
0.1 |
Assay in serum |
80 |
100.2 |
0.1 |
100 |
0.1 |
100 |
0.1 |
100 |
100 |
0.2 |
100.2 |
0.2 |
100.2 |
0.1 |
120 |
100.2 |
0.2 |
100.3 |
0.1 |
100.3 |
0.2 |
HCT: hydrochlorothiazide; ENP: enalapril; FRS: furosemide |